SL Investment

SL Investment is a venture capital firm based in Seoul, South Korea, established in February 2000. The firm focuses on investing in small and medium-sized companies across various sectors, including biotechnology, healthcare, semiconductors, display technologies, renewable energy, and artificial intelligence. SL Investment has a strong track record, having achieved positive financial results for 12 consecutive years without incurring any debt. The firm not only provides capital but also actively supports the management of its portfolio companies to enhance their value. Over the years, SL Investment has successfully facilitated the listing of 31 companies on the KOSDAQ market, helping them to become leaders in their respective industries.

Minju Ahn

Managing Director

Jae-Sung Han

Managing Director

Hwanseok Jeon

Managing Director and Investment Officer

Jeon Hwan-seok

Managing Director and Investment Professional

Jong Wook Kim

CEO

Seunghun Lee

CEO

Sangjik Lee

Executive Director and Investment Professional

Minju Ahn Ph.D

Executive Director and Investment Professional

35 past transactions

Youniv

Venture Round in 2023
Operator of a digital media and content production company intended to serve students who are Generation Z. The Company creates content that students need so that they can empathize with them, enabling students to increase their knowledge.

D'Cent

Series A in 2021
D'Cent specializes in providing cryptocurrency hardware wallets designed to secure digital assets. The company offers a range of embedded security services aimed at protecting customers' virtual currencies. Its products include digital asset cold storage, secure private key storage, and transaction execution solutions, which combine both software and hardware security measures. By focusing on secure connectivity solutions, D'Cent ensures that customers can confidently manage and safeguard their digital assets.

UrbanPlay

Series A in 2021
UrbanPlay Inc. is a Seoul-based company established in 2013 that focuses on creating and curating urban culture content. The company collects and processes both tangible and intangible materials related to urban issues, providing a platform that facilitates engagement with these topics in innovative ways. UrbanPlay offers a range of online services, regional projects, multimedia content, and publications, all designed to foster a deeper understanding of urban environments. Additionally, the company operates a community platform that delivers various real estate content services, including space offerings, publishing, merchandise, and local marketing. By leveraging creators' contributions, UrbanPlay aims to build a sustainable urban cultural ecosystem that enhances neighborhood lifestyle services for users.

N.thing

Series B in 2021
N.thing, Inc. is a South Korean company founded in January 2014, specializing in IoT technology for the gardening and agriculture sectors. Headquartered in Seoul, with a North American branch in New York, the company aims to connect people with nature through innovative solutions. N.thing offers a range of products, including the Planty Cube, an internet-connected indoor farm equipped with LED technology and real-time monitoring, and the Planty Square, a modular hydroponic kit that allows users to grow various plants easily. Additionally, Planty serves as the world's first internet-connected social pot, enabling users to monitor their plants' conditions and share their gardening experiences. The company also provides a smart gardening journal called Life, which helps plant enthusiasts document and share their gardening activities on social media. N.thing's mission is to enhance the gardening experience by integrating technology, making it accessible for anyone to engage in farming and plant care.

N.thing

Series B in 2021
N.thing, Inc. is a South Korean company founded in January 2014, specializing in IoT technology for the gardening and agriculture sectors. Headquartered in Seoul, with a North American branch in New York, the company aims to connect people with nature through innovative solutions. N.thing offers a range of products, including the Planty Cube, an internet-connected indoor farm equipped with LED technology and real-time monitoring, and the Planty Square, a modular hydroponic kit that allows users to grow various plants easily. Additionally, Planty serves as the world's first internet-connected social pot, enabling users to monitor their plants' conditions and share their gardening experiences. The company also provides a smart gardening journal called Life, which helps plant enthusiasts document and share their gardening activities on social media. N.thing's mission is to enhance the gardening experience by integrating technology, making it accessible for anyone to engage in farming and plant care.

SeaWith

Series A in 2021
Producer of clean meat intended to prevent raising and slaughtering of livestock from existing livestock settings. The company develops clean meat, which is no different than actual meat, in a laboratory using their own cell culture medium using algae and 3-dimensional structures using seaweed, providing customers with cultured meat that is delicious and affordable.

Sir.Loin

Series B in 2021
Operator of an online meat-selling platform intended to offer quality meat-based products. The company manages the overall process from feeding, breeding, aging, and processing of the meat, enabling customers to receive quality meat directly without any hassle.

WHYNOT Media

Series C in 2021
WHYNOT Media Co., Ltd. is a South Korean company established in 2016 that specializes in developing and operating a video content streaming platform. The company focuses on producing and distributing a variety of entertainment content, including web series, short films, and web dramas. Notable titles in its portfolio include "Secret Crushes," "Always a Boyfriend," "Never a Boyfriend," and "Office Watch." By tailoring its content to fit specific cultural backgrounds, WHYNOT Media aims to enhance viewer engagement and accessibility, thereby creating a diverse range of entertainment options for its audience.

Nexel

Series B in 2021
Operator of a biotechnology company intended to provide drug discovery pipelines to treat diseases. The company develops high-quality iPSC-derived cell products through embryonic stem cell technology, enabling clients to conquer unmet medical needs and iPSC technology

Biobab AiBIO

Series A in 2021
Biobab AiBIO is a biotechnology company that develops drugs utilize artificial intelligence.

ImmunoMet

Venture Round in 2021
ImmunoMet Therapeutics, Inc. is a biopharmaceutical company based in Houston, Texas, focused on developing and commercializing innovative oncology drugs. Since its incorporation in 2015, the company has concentrated on therapies that enhance the quality of life for cancer patients. Its pipeline includes metabolic regulators that specifically target the cellular metabolism of drug-resistant cancer subpopulations, as well as immuno-suppressors that affect anti-cancer effector T cells. By disrupting cancer metabolism and bolstering anti-cancer immunity, ImmunoMet aims to improve patient survival rates and overall well-being.

Lab n People

Series B in 2020
Lab & People is a HealthTech company that is improving the drug delivery system. We have developed a microneedle patch using bioabsorbable metals. Our microneedle patch uses thin, soft needles that penetrate directly into the skin layer containing gout cells, thus minimizing pain. It also increases transmission efficiency by using metals such as magnesium, zinc, and calcium, which are highly absorbable by the body. We have four products: 1. Flexible bioabsorbable metal Our flexible bioabsorbable metal technology secures biocompatibility according to ISO 10993. 19 kinds of materials were developed to provide mechanical properties. Decomposition characteristics can be controlled. Our wire rods are of similar technology to that produced by industry leader Fort Wayne Metals in the United States, and we are the only company producing this kind of metal plate worldwide. Innovative materials and products can be supplied to the implant and drug delivery market at an unrivaled level. 2. Bioabsorbable metal implant Micro-invasive aesthetic medical devices can lift faces, breasts, thighs, etc. within 15 minutes. We are expected to start clinical trials with this technology in 2021, with approval by 2022. After initial approval, material-related safety data can be used in the same way, thus securing a product portfolio and accelerating the approval period and commerical competitiveness over time. 3. Bioabsorbable metal microneedle We are the first in the world to commercialize microneedles with flexible bioabsorbable metal using only essential elements in the human body. In Korea, sales are expanding through our own distribution network (on/offline in Olive Young in 2020), and exports are expanding to Japan, Singapore, Hong Kong, and Russia. Our Microneedle Patch is a platform technology that enables the development of derivative products for each disease. NDAs (Confidentiality agreement) with global companies and pharmaceutical companies have been signed and discussions for cooperation are being initiated. 4. Minimal invasive medical device Minimally-invasive medical devices for treatment of spinal stenosis can remove lesions that cause spinal stenosis within 30 minutes without surgery. This technology is currently in the approval stage with the KFDA and is preparing for mass production. We are expected to generate sales from 2021.

SN BioScience

Series B in 2020
SN BioScience provide nano-formulation screening services for small molecule, oligonucleotide (siRNA, DNA), peptide and protein to deliver in the form of nano-micelle, nanoparticle or liposome. Their proprietary “double core-shell technology” and pool of acceptable lipids and polymers could help your research that having difficulties in solubility or delivery.

UrbanPlay

Series A in 2019
UrbanPlay Inc. is a Seoul-based company established in 2013 that focuses on creating and curating urban culture content. The company collects and processes both tangible and intangible materials related to urban issues, providing a platform that facilitates engagement with these topics in innovative ways. UrbanPlay offers a range of online services, regional projects, multimedia content, and publications, all designed to foster a deeper understanding of urban environments. Additionally, the company operates a community platform that delivers various real estate content services, including space offerings, publishing, merchandise, and local marketing. By leveraging creators' contributions, UrbanPlay aims to build a sustainable urban cultural ecosystem that enhances neighborhood lifestyle services for users.

WHYNOT Media

Series B in 2019
WHYNOT Media Co., Ltd. is a South Korean company established in 2016 that specializes in developing and operating a video content streaming platform. The company focuses on producing and distributing a variety of entertainment content, including web series, short films, and web dramas. Notable titles in its portfolio include "Secret Crushes," "Always a Boyfriend," "Never a Boyfriend," and "Office Watch." By tailoring its content to fit specific cultural backgrounds, WHYNOT Media aims to enhance viewer engagement and accessibility, thereby creating a diverse range of entertainment options for its audience.

Lab n People

Seed Round in 2019
Lab & People is a HealthTech company that is improving the drug delivery system. We have developed a microneedle patch using bioabsorbable metals. Our microneedle patch uses thin, soft needles that penetrate directly into the skin layer containing gout cells, thus minimizing pain. It also increases transmission efficiency by using metals such as magnesium, zinc, and calcium, which are highly absorbable by the body. We have four products: 1. Flexible bioabsorbable metal Our flexible bioabsorbable metal technology secures biocompatibility according to ISO 10993. 19 kinds of materials were developed to provide mechanical properties. Decomposition characteristics can be controlled. Our wire rods are of similar technology to that produced by industry leader Fort Wayne Metals in the United States, and we are the only company producing this kind of metal plate worldwide. Innovative materials and products can be supplied to the implant and drug delivery market at an unrivaled level. 2. Bioabsorbable metal implant Micro-invasive aesthetic medical devices can lift faces, breasts, thighs, etc. within 15 minutes. We are expected to start clinical trials with this technology in 2021, with approval by 2022. After initial approval, material-related safety data can be used in the same way, thus securing a product portfolio and accelerating the approval period and commerical competitiveness over time. 3. Bioabsorbable metal microneedle We are the first in the world to commercialize microneedles with flexible bioabsorbable metal using only essential elements in the human body. In Korea, sales are expanding through our own distribution network (on/offline in Olive Young in 2020), and exports are expanding to Japan, Singapore, Hong Kong, and Russia. Our Microneedle Patch is a platform technology that enables the development of derivative products for each disease. NDAs (Confidentiality agreement) with global companies and pharmaceutical companies have been signed and discussions for cooperation are being initiated. 4. Minimal invasive medical device Minimally-invasive medical devices for treatment of spinal stenosis can remove lesions that cause spinal stenosis within 30 minutes without surgery. This technology is currently in the approval stage with the KFDA and is preparing for mass production. We are expected to generate sales from 2021.

SOS LAB

Series A in 2018
SOS Lab. Co., Ltd. designs, develops, and manufactures optical measurement sensors based on LiDAR technologies for autonomous vehicles. The company's products include SL-1 for self driven cars; GL-3 for drones, robots, or industrial automation systems; and TL-3 for subway screen doors. The company was founded in 2016 and is based in Gwangju, South Korea.

JLK

Venture Round in 2018
JLK, Inc. provides diagnosis support to the patients with it AI-driven solutions in South Korea. The company offers AI medical and AI security solutions. Its AI platform provides the on-site/real-time service that is connected to various systems built in the hospital and enables the professional needs of physicians to diagnose diseases. The company provides medical management, medical treatment, and medical service in brain diseases, such as ischemic stroke, hemorrhagic stroke, brain aneurysm, and Alzheimer’s disease; and in lung diseases, coronary artery disease, prostate cancer, and digital pathology. The company was formerly known as JLK INSPECTION Co.,Ltd. JLK, Inc. is headquartered in Cheongju, South Korea.

Caret Games

Venture Round in 2018
Caret Games is a company specialized in developing mobile games with over 50 employees based on South Korea. The company consists of talented developers and they are developing games with passion. Caret Games developed Full3D mobile MMORPG ‘RebirthM’ in the end of 2017. The company is trying to make a game which many people can enjoy and play for a long time, and the first is ‘RebirthM’. Caret Games services 'RebirthM'​ directly in South Korea and is currently preparing for global service. About "Rebirth M"​! The game also known as Rebirth: Shadow of Salvation, is a mobile MMORPG that’s supposed to rival PC MMORPGs. Made with Unity3D, the game boasts high graphics and PC-like gameplay experience. Now that it’s been more than a year since its announcement in South Korea, the game is finally out in Brazil which a global release will follow suit later.

Urbanbase

Venture Round in 2017
Urbanbase Inc. is a South Korean company founded in 2014 that specializes in a design platform transforming two-dimensional floor plans into three-dimensional models. The company has developed patented technology that allows for the rapid conversion of 2D designs into 3D, augmented reality (AR), and virtual reality (VR) formats. Urbanbase provides a consumer-facing VR home furnishing platform and an AR mobile application, enhancing the interior design experience. Additionally, it offers a business-to-business sales tool utilizing its internally developed 3D, AR, and VR APIs, which serve a variety of sectors, including real estate, home design, and retail. Urbanbase's clientele includes notable companies such as LG, iLoom, and Daelim, as well as over 40 other interior and furniture businesses.

Urbanbase

Series A in 2017
Urbanbase Inc. is a South Korean company founded in 2014 that specializes in a design platform transforming two-dimensional floor plans into three-dimensional models. The company has developed patented technology that allows for the rapid conversion of 2D designs into 3D, augmented reality (AR), and virtual reality (VR) formats. Urbanbase provides a consumer-facing VR home furnishing platform and an AR mobile application, enhancing the interior design experience. Additionally, it offers a business-to-business sales tool utilizing its internally developed 3D, AR, and VR APIs, which serve a variety of sectors, including real estate, home design, and retail. Urbanbase's clientele includes notable companies such as LG, iLoom, and Daelim, as well as over 40 other interior and furniture businesses.

Wantedlab

Series B in 2017
Wantedlab, Inc. operates a crowd recruiting platform that enables users to refer applicants to companies and receive rewards upon successful hires. Founded in 2015 and headquartered in Seoul, South Korea, the platform has attracted over 5,000 companies and hundreds of thousands of users. Notable clients include major organizations such as IBM, Facebook, Microsoft, eBay, WeWork, Rakuten, and Tencent, which utilize Wanted to identify top talent in Asia. Since its inception, the company has raised over $20 million in funding and is actively expanding its operations to other major cities globally.

ImmunoMet

Series B in 2017
ImmunoMet Therapeutics, Inc. is a biopharmaceutical company based in Houston, Texas, focused on developing and commercializing innovative oncology drugs. Since its incorporation in 2015, the company has concentrated on therapies that enhance the quality of life for cancer patients. Its pipeline includes metabolic regulators that specifically target the cellular metabolism of drug-resistant cancer subpopulations, as well as immuno-suppressors that affect anti-cancer effector T cells. By disrupting cancer metabolism and bolstering anti-cancer immunity, ImmunoMet aims to improve patient survival rates and overall well-being.

InnoSpark

Series B in 2015
InnoSpark Inc. is a mobile game development company based in Seoul, South Korea, founded in 2012. The company focuses on creating traffic-oriented network games that emphasize social interaction. Its portfolio includes combat strategy games and social dragon breeding games, aiming to engage users through innovative gameplay experiences. InnoSpark is dedicated to developing and publishing games that appeal to a global audience.

The News Funnel

Angel Round in 2014
A free real estate news aggregation & PR tool website for the busy professional. Stay up-to-date on RE news that is customized to your unique interests.

ChannelBreeze

Venture Round in 2013
ChannelBreeze (채널브리즈) is a Korean company that provides social commerce services through an online platform including social network services. ChannelBreeze also provides search engine-based web services for real estate.

ZigBang

Seed Round in 2011
Zig Bang, an apartment hunting app from Korea. Users on Zig Bang can search for rental properties by the number of rooms, occupants, and price. Across both mobile and web versions, the startup reports 6 million users (though those aren’t all necessarily active and there might be some overlap). The goal for 2015 is to hit 10 million and potentially seek another funding round.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.